EFFICACY AND TOLERABILITY OF AMLODIPINE/TELMISARTAN COMBINATION THERAPY IN HYPERTENSIVE PATIENTS WITH CARDIOVASCULAR RISK FACTORS

被引：0
|
作者：
不详
机构：
来源：
HEART | 2012年 / 98卷
关键词：
D O I：
10.1136/heartjnl-2012-302920j.59
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E180 / E180
页数：1
相关论文
共 50 条
  • [1] Efficacy and tolerability of telmisartan plus amlodipine in added-risk hypertensive patients
    Guthrie, Robert M.
    Dahlof, Bjorn
    Jamerson, Kenneth A.
    Olvera, Rafael
    Seeber, Mary
    Schumacher, Helmut
    Oigman, Wille
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (10) : 1995 - 2008
  • [2] Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with Amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors:: The VAST study
    Ruilope, LM
    Malacco, E
    Khder, Y
    Kandra, A
    Bönner, G
    Heintz, D
    CLINICAL THERAPEUTICS, 2005, 27 (05) : 578 - 587
  • [3] Efficacy and tolerability of amlodipine/valsartan combination therapy in hypertensive patients not adequately controlled on amlodipine monotherapy
    Schunkert, H.
    Glazer, R. D.
    Wernsing, M.
    Yen, J.
    Macarie, C. E.
    Vintila, M. M.
    Romanova, J.
    CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (11) : 2655 - 2662
  • [4] Efficacy and tolerability of amlodipine/valsartan combination therapy in hypertensive patients not adequately controlled on valsartan monotherapy
    Sinkiewicz, W.
    Glazer, R. D.
    Kavoliuniene, A.
    Miglinas, M.
    Prak, H.
    Wernsing, M.
    Yen, J.
    CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (02) : 315 - 324
  • [5] EFFICACY AND TOLERABILITY OF TRIPLE COMBINATION THERAPY WITH AMLODIPINE/VALSARTAN/HYDROCHLOROTHIAZIDE COMPARED TO DUAL COMBINATION THERAPY IN MODERATE TO SEVERE HYPERTENSIVE PATIENTS
    Calhoun, D.
    Glazer, R.
    Yen, J.
    Lacourciere, Y.
    JOURNAL OF HYPERTENSION, 2009, 27 : S7 - S7
  • [6] Efficacy of combination therapy with telmisartan plus amlodipine in patients with poorly controlled hypertension
    Bekki, Hisatoshi
    Yamamoto, Kiichiro
    Sone, Masayoshi
    Homma, Tomoki
    Nakata, Masashi
    Nohara, Masatoshi
    Fukami, Kei
    Okuda, Seiya
    Yamagishi, Sho-ichi
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2010, 3 (05) : 342 - 346
  • [7] Comparison of efficacy and safety of azilsartan amlodipine combination versus telmisartan amlodipine combination in hypertensive patients: A non- inferiority trial
    Meher, Bikash
    Dash, Ashish
    Mohanty, Rashmi
    Padhy, Biswa
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 : 305 - 306
  • [8] Comparison of Efficacy and Safety of Azilsartan and Amlodipine Combination Versus Telmisartan and Amlodipine Combination in Hypertensive Patients: A Non-inferiority Trial
    Dash, Ashish
    Meher, Bikash R.
    Padhy, Biswa M.
    Mohanty, Rashmi R.
    Tripathy, Amruta
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (03)
  • [9] COMBINATION OF AMLODIPINE WITH DIURETICS OR TELMISARTAN IN HIGH-RISK HYPERTENSIVE PATIENTS: THE CHINESE HYPERTENSION INTERVENTION EFFICACY STUDY (CHIEF)
    Wang, Wen
    Zhang, Yuqing
    Ma, Liyuan
    Lu, Peipei
    Meng, Xu
    Li, Yanqi
    Wang, Shu
    Zhang, Xuezhong
    Ma, Lihong
    Zhou, Xianliang
    Liu, Lisheng
    Hu, Aihua
    JOURNAL OF HYPERTENSION, 2018, 36 : E260 - E260
  • [10] Efficacy and Tolerability of Telmisartan Plus Amlodipine in Asian Patients Not Adequately Controlled on Either Monotherapy or on Low-Dose Combination Therapy
    Zhu, Dingliang
    Gao, Pingjin
    Yagi, Nobutaka
    Schumacher, Helmut
    INTERNATIONAL JOURNAL OF HYPERTENSION, 2014, 2014
12345